Harnessing the power of structure‐based design: A new lease on life for cardiovascular drug development with apelin receptor modulators
Saved in:
Main Authors: | Junxia Zhang, Erdan Dong, Yan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.70116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The future of G protein‐coupled receptor therapeutics: Apelin receptor acts as a prototype for the advancement of precision drug design
by: Wei‐Wei Wang, et al.
Published: (2024-12-01) -
Structural insights into the regulation of monomeric and dimeric apelin receptor
by: Yang Yue, et al.
Published: (2025-01-01) -
A New Lease of Life for the Aosta Valley’s Consorterie
by: Roberto Louvin, et al.
Published: (2021-04-01) -
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
by: Reham Z. Hamza, et al.
Published: (2021-01-01) -
Harnessing the power of seaweed: unveiling the potential of marine algae in drug discovery
by: Leonel Pereira, et al.
Published: (2023-12-01)